
On Thursday evening, Skadden, Arps, Slate, Meagher & Flom, a top grossing US law firm, announced that their new top leader will be Jeremy London, a corporate partner based in Washington, DC.
Jeremy London will replace Eric Friedman as the executive partner of the 1,600-lawyer firm. According to a statement from Friedman, the partnership made an excellent choice in selecting London for the role.
According to data collected by The American Lawyer, Skadden’s annual revenue under Friedman increased to $3 billion in 2022. There were slight drops in 2009 and 2020, but the average profits for its 321 equity partners reached $5 million.
Read more: Skadden Won’t Represent TikTok In Meta Antitrust Lawsuit
The firm’s head count declined during Friedman’s tenure, however, from 2,200 lawyers when he took over in 2008 to more than 1,600 lawyers in 2022.
“Through his steadfast leadership, Eric Friedman has personified our values, enriched our culture and positioned us for ongoing success,” London said in a statement.
London has worked at Skadden since 1996, starting as a summer associate. One of his top clients is Centene Corp and he represented them during their acquisitions of WellCare, Health Net, and Magellan Health Inc, according to his Skadden profile.
Featured News
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Live Nation Under Criminal Antitrust Investigation Over Pandemic-Era Refund Policies
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas